Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

NCT05292859 · clinicaltrials.gov ↗

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Gynecologic Cancer
Colorectal Cancer
Pancreatic Cancer
Non-small Cell Lung Cancer
Cholangiocarcinoma
Ovarian Cancer
Ovary Neoplasm
Squamous Cell Lung Cancer
Adenocarcinoma of Lung
Adenosquamous Cell Lung Cancer

Interventions

BIOLOGICAL: Neoantigen specific TCR-T cell drug product

Sponsor

Alaunos Therapeutics